Efflux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide)

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1594-1600

  Richmond, G E ^a   Chua, K L ^b   Piddock, L J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibiotics; MDR; Resistance nodulation division

Indexed keywords

ANTIBIOTIC AGENT; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; ETHIDIUM BROMIDE; HOE 33342; NORFLOXACIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM EFFLUX; BACTERIUM ISOLATE; CELL MEMBRANE PERMEABILITY; DELETION MUTANT; ENZYME SPECIFICITY; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NODULATION; NONHUMAN;

EID: 84879472905     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt052     Document Type: Article

References (34)

1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
2. Livermore DM, Hope R, Brick G et al. Non-9susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62 Suppl 2: ii55-63.
3. Jawad A, Seifert H, Snelling AM et al. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36: 1938-41.
4. Wendt C, Dietze B, Dietz E et al. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997; 35: 1394-7.
5. Coyne S, Courvalin P, Perichon B. Efflux-iimediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011; 55: 947-53.
6. Marchand I, Damier-9Piolle L, Courvalin P et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004; 48: 3298-304.
7. Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001; 45: 3375-80.
8. Damier-Piolle L, Magnet S, Bremont S et al. AdeIJK, a resistancenodulation- cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 2008; 52: 557-62.
9. Coyne S, Guigon G, Courvalin P et al. Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray. Antimicrob Agents Chemother 2010; 54: 333-40.
10. Coyne S, Rosenfeld N, Lambert T et al. Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 4389-93.
11. Roca I, Marti S, Espinal P et al. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 4013-4.
12. Rajamohan G, Srinivasan VB, Gebreyes WA. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 1919-25.
13. Su XZ, Chen J, Mizushima T et al. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob Agents Chemother 2005; 49: 4362-4.
14. Srinivasan VB, Rajamohan G, Gebreyes WA. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 5312-6.
15. Yun S-H, Choi C-W, Park S-H et al. Proteomic analysis of outer membrane proteins from Acinetobacter baumannii DU202 in tetracycline stress condition. J Microbiol 2008; 46: 720-7.
16. Bou G, Cervero G, Dominguez MA et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of b-lactamases. J Clin Microbiol 2000; 38: 3299-305.
17. Hwa WE, Subramaniam G, Mansor MB et al. Iron regulated outer membrane proteins (IROMPs) as potential targets against carbapenemresistant Acinetobacter spp. isolated from a Medical Centre in Malaysia. Indian J Med Res 2010; 131: 578-83.
18. Tomas MDM, Beceiro A, Perez A et al. Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 5172-5.
19. Piddock LJV, White DG, Gensberg K et al. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44: 3118-21.
20. Mortimer PG, Piddock LJ. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1991; 28: 639-53.
21. Babayan A, Nikaido H. In Pseudomonas aeruginosa ethidium bromide does not induce its own degradation or the assembly of pumps involved in its efflux. Biochem Biophys Res Commun 2004; 324: 1065-8.
22. Durand RE, Olive PL. Cytotoxicity, mutagenicity and DNA damage by Hoechst 33342. J Histochem Cytochem 1982; 30: 111-6.
23. Lalande ME, Ling V, Miller RG. Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci USA 1981; 78: 363-7.
24. van den Berg van Saparoea HB, Lubelski J, van Merkerk R et al. Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. Biochemistry 2005; 44: 16931-8.
25. Huda N, Lee E-W, Chen J et al. Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob Agents Chemother 2003; 47: 2413-7.
26. Coldham NG, Webber M, Woodward MJ et al. A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. J Antimicrob Chemother 2010; 65: 1655-3.
27. Hornsey M, Ellington MJ, Doumith M et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 1589-93.
28. Higgins PG, Lehmann M, Wisplinghoff H et al. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 2010; 48: 4592-4.
29. Higgins PG, Wisplinghoff H, Krut O et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect 2007; 13: 1199-201.
30. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
31. Mortimer PG, Piddock LJ. The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli. J Antimicrob Chemother 1993; 32: 195-213.
32. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-16.
33. Yu EW, Aires JR, McDermott G et al. A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J Bacteriol 2005; 187: 6804-15.
34. Henderson JF. Application of the chemiosmotic theory to the transport of lactose, D-galactose and L-arabinose by Escherichia coli. In: Bolis L, Bloch K, Luria SE et al., eds. Comparative Biochemistry and Physiology of Transport. Amsterdam: North-Holland Publishing Company, 1974; 409-24.